Company attributes
Location
B2X
CEO
Founder
Pitchbook URL
Legal Name
Absci Corporation
Date Incorporated
2011
Number of Employees (Ranges)
51 – 2000
Email Address
info@absci.com0
Phone Number
+150320878820
+13609491041
Number of Employees
2120
Full Address
101 E 6th St, Vancouver, WA 98660, US
CIK Number
Investors
DUNS Number
78413876
Founded Date
2011
0Total Funding Amount (USD)
437,899,976
Latest Funding Round Date
July 22, 2021
Competitors
Latest Funding Type
Patents Assigned (Count)
1
Country
Other attributes
Company Operating Status
Active
Invested in
Latest Funding Round Amount (USD)
200,000,000
Ticker Symbol
ABSI
AbSci is a synthetic biology company that translates ideas into drugs with a platform technology that reinvents the biopharmaceutical drug discovery process. The company custom engineers E. coli to create complex biologics in their full length format while simultaneously developing production cell lines.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
